The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Hospitalizations and Mortality in the Lung Health Study
Abstract
This report deals with deaths and hospitalizations during the 5-year Lung Health Study, as documented by examination of appropriate records. There were 149 deaths (2.5%) during the study, caused largely by lung cancer and cardiovascular disease, particularly coronary heart disease. A total of 12.8% of participants were hospitalized, with cancer, cardiovascular disease, and nonmalignant respiratory disease accounting for 75% of hospitalizations. There were no significant differences among the original treatment groups for all-cause mortality, lung cancer, or hospitalizations for respiratory disease. Deaths and hospitalizations for cardiovascular disease and coronary artery disease were more common in the smoking intervention plus Atrovent inhaler (SI-A) group, which received ipratropium bromide, than in the smoking intervention plus placebo inhaler (SI-P) group, which received placebo, and the differences approached statistical significance. However, we were unable to find a dose effect, in that differences were not related to self-reported inhaler compliance. In the SI-A group, nine participants were hospitalized for supraventricular tachycardia as compared with two in the SI-P group, and SI-A participants with this condition were unusually compliant with their inhaled medication. When all participants were considered and smoking status considered as a time-dependent covariate, smoking cessation was associated with significant reductions in fatal or nonfatal cardiovascular disease and coronary artery disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiple Risk Factor Intervention Trial: Risk Factor Changes and Mortality Results
(1982) · JAMA · doi:10.1001/jama.1982.03330120023025 · Cited by 1,722
Anthonisen, N. R. (1994) · JAMA · doi:10.1001/jama.1994.03520190043033 · Cited by 1,341
Self-citationSCANLON, P. D., CONNETT, J. E., WALLER, L. A., ALTOSE, M. D., BAILEY, W. C., SONIA BUIST, A., & e Lung Health Study Research Group, D. P. T. F. T. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.9901044 · Cited by 731
Self-citationConnett, J. E., Kusek, J. W., Bailey, W. C., O’Hara, P., & Wu, M. C. (1993) · Controlled Clinical Trials · doi:10.1016/0197-2456(93)90021-5 · Cited by 124
Self-citationThe Risk of Myocardial Infarction Associated with Inhaled β -Adrenoceptor Agonists
Au, D. H., Lemaître, R. N., Curtis, J. R., et al. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.3.9904006 · Cited by 124
Cigarette smoking and mortality
Kuller, L. H., Ockene, J. K., Meilahn, E. N., Wentworth, D. N., Svendsen, K. H., & Neaton, J. D. (1991) · Preventive Medicine · doi:10.1016/0091-7435(91)90060-h · Cited by 112
Guite, H. F., Dundas, R., & Burney, P. (1999) · Thorax · doi:10.1136/thx.54.4.301 · Cited by 67
Sin, D. D. (2000) · Thorax · doi:10.1136/thorax.55.3.194 · Cited by 34
Cited by
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0218pp · Cited by 3,187
Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary Disease
Divo, M., Cote, C., de Torres, J. P., Casanova, C., Marin, J. M., Pinto-Plata, V., Zulueta, J., Cabrera, C., Zagaceta, J., Hunninghake, G., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201201-0034oc · Cited by 1,275
The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality: A Randomized Clinical Trial
Anthonisen, N. R., Skeans, M. A., Wise, R. A., Manfreda, J., Kanner, R. E., Connett, J. E., & for the Lung Health Study Research Group* (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-4-200502150-00005 · Cited by 1,237
Self-citationVogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00214-2017 · Cited by 881
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Cazzola, M., MacNee, W., Martinez, F. J., Rabe, K. F., Franciosi, L. G., Barnes, P. J., Brusasco, V., Burge, P. S., Calverley, P. M. A., Celli, B. R., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00099306 · Cited by 858
The Pathology of Chronic Obstructive Pulmonary Disease
Hogg, J. C., & Timens, W. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092145 · Cited by 845
O’Donnell, D. E., Aaron, S., Bourbeau, J., Hernandez, P., Marciniuk, D. D., Balter, M., Ford, G., Gervais, A., Goldstein, R., Hodder, R., et al. (2007) · Canadian Respiratory Journal · doi:10.1155/2007/830570 · Cited by 693
Vogelmeier, C. F., Criner, G. J., Martinez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · Respirology · doi:10.1111/resp.13012 · Cited by 681
Chronic Obstructive Pulmonary Disease as a Risk Factor for Cardiovascular Morbidity and Mortality
Sin, D. D., & Man, S. F. P. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200404-032ms · Cited by 572
Increased Risk of Myocardial Infarction and Stroke Following Exacerbation of COPD
Donaldson, G. C., Hurst, J. R., Smith, C. J., Hubbard, R. B., & Wedzicha, J. A. (2010) · Chest · doi:10.1378/chest.09-2029 · Cited by 514
Feary, J. R., Rodrigues, L. C., Smith, C. J., Hubbard, R. B., & Gibson, J. E. (2010) · Thorax · doi:10.1136/thx.2009.128082 · Cited by 445
COPD Guidelines: A Review of the 2018 GOLD Report
Mirza, S., Clay, R. D., Koslow, M. A., & Scanlon, P. D. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.05.026 · Cited by 444
Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort
Miller, J., Edwards, L. D., Agustí, A., Bakke, P., Calverley, P. M. A., Celli, B., Coxson, H. O., Crim, C., Lomas, D. A., Miller, B. E., et al. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.05.001 · Cited by 437
Cardiovascular Morbidity and Mortality in COPD
Huiart, L., Ernst, P., & Suissa, S. (2005) · Chest · doi:10.1378/chest.128.4.2640 · Cited by 424
Contemporary Management of Chronic Obstructive Pulmonary Disease: Scientific Review
Sin, D. D., McAlister, F. A., Man, S. F. P., & Anthonisen, N. R. (2003) · JAMA · doi:10.1001/jama.290.17.2301 · Cited by 404
Self-citationC-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease
Man, S. F. P. (2006) · Thorax · doi:10.1136/thx.2006.059808 · Cited by 397
Effects of Fluticasone on Systemic Markers of Inflammation in Chronic Obstructive Pulmonary Disease
Sin, D. D., Lacy, P., York, E., & Man, S. F. P. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-543oc · Cited by 347
Vogelmeier, C. F., Criner, G. J., Martínez, F. J., Anzueto, A., Barnes, P. J., Bourbeau, J., Celli, B. R., Chen, R., Decramer, M., Fabbri, L. M., et al. (2017) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2017.02.001 · Cited by 309
McAllister, D. A., Maclay, J. D., Mills, N. L., Mair, G., Miller, J., Anderson, D., Newby, D. E., Murchison, J. T., & MacNee, W. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1080oc · Cited by 292
COPD-related morbidity and mortality after smoking cessation: status of the evidence
Godtfredsen, N. S., Lam, T. H., Hansel, T. T., Leon, M. E., Gray, N., Dresler, C., Burns, D. M., Prescott, E., & Vestbo, J. (2008) · European Respiratory Journal · doi:10.1183/09031936.00160007 · Cited by 279
COPD and multimorbidity: Recognising and addressing a syndemic occurrence
Fabbri, L. M., Celli, B. R., Agustí, A., Criner, G. J., Dransfield, M. T., Divo, M., Krishnan, J. K., Lahousse, L., Montes de Oca, M., Salvi, S. S., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00261-8 · Cited by 274
Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
Finkelstein, J., Cha, E., & Scharf, S. (2009) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s6400 · Cited by 267
The natural history of chronic obstructive pulmonary disease
Mannino, D. M., Watt, G., Hole, D., Gillis, C., Hart, C., McConnachie, A., Davey Smith, G., Upton, M., Hawthorne, V., Sin, D. D., et al. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00024605 · Cited by 265
Cardiovascular Disease in COPD
Maclay, J. D., & MacNee, W. (2013) · Chest · doi:10.1378/chest.12-0938 · Cited by 257
Mortality in COPD: Causes, Risk Factors, and Prevention
Berry, C. E., & Wise, R. A. (2010) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2010.510160 · Cited by 257
Neurohumoral activation as a link to systemic manifestations of chronic lung disease
Andreas, S., Anker, S. D., Scanlon, P. D., & Somers, V. K. (2005) · Chest · doi:10.1378/chest.128.5.3618 · Cited by 243
Soukup, O., Winder, M., Killi, U. K., Wsol, V., Jun, D., Kuca, K., & Tobin, G. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666160607212615 · Cited by 34
Vazquez Guillamet, R., Ursu, O., Iwamoto, G., Moseley, P. L., & Oprea, T. (2018) · Health Informatics Journal · doi:10.1177/1460458216675661 · Cited by 30
TNFα receptor genotype influences smoking-induced muscle-fibre-type shift and atrophy in mice
De Paepe, B., Brusselle, G. G., Maes, T., Creus, K. K., D’hose, S., D’Haese, N., Bracke, K. R., D’hulst, A. I., Joos, G. F., & De Bleecker, J. L. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0348-4 · Cited by 29
Metadata
- Authors
- Anthonisen, N. R., Connett, J. E., Enright, P. L., & Manfreda, J.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-08-01
- Volume
- 166
- Issue
- 3
- Pages
- 333-339
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W1997243264
- Cited by
- 588
- References
- 8
- FWCI
- 11.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.